Ekso Bionics Holdings logo

Ekso Bionics HoldingsNASDAQ: EKSO

Profile

Sector:

Healthcare

Country:

United States

IPO:

17 January 2014

Next earnings report:

04 March 2025

Last dividends:

N/A

Next dividends:

N/A
$15.62 M
-65%vs. 3y high
22%vs. sector
-vs. 3y high
-vs. sector
-70%vs. 3y high
40%vs. sector
-81%vs. 3y high
22%vs. sector

Price

after hours | 71 min ago
$0.71+$0.00(+0.14%)

Dividend

No data over the past 3 years
$4.13 M$5.30 M
$4.13 M-$2.07 M

Analysts recommendations

Institutional Ownership

EKSO Latest News

Ekso Bionics to Showcase Its Device Technology in ‘AI for Good' Webinar on Tuesday, November 19
globenewswire.com18 November 2024 Sentiment: POSITIVE

SAN RAFAEL, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Katherine Strausser, Principal Controls Engineer at Ekso Bionics, will be participating in an ‘AI for Good' webinar.

Ekso Bionics to Participate at the 15th Annual Craig-Hallum Alpha Select Conference
globenewswire.com12 November 2024 Sentiment: POSITIVE

SAN RAFAEL, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, Chief Executive Officer, and Jerome Wong, Chief Financial Officer, will be participating at the 15th Annual Craig-Hallum Alpha Select Conference taking place in New York on Tuesday, November 19, 2024.

Ekso Bionics (EKSO) Reports Q3 Loss, Misses Revenue Estimates
zacks.com28 October 2024 Sentiment: NEGATIVE

Ekso Bionics (EKSO) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to loss of $0.24 per share a year ago.

Ekso Bionics Holdings, Inc. (EKSO) Q3 2024 Earnings Call Transcript
seekingalpha.com28 October 2024 Sentiment: NEUTRAL

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO ) Q3 2024 Earnings Conference Call October 28, 2024 4:30 PM ET Company Participants Matt Steinberg - Finn Partners Scott Davis - Chief Executive Officer Jerome Wong - Chief Financial Officer Conference Call Participants Ben Haynor - Lake Street Capital Markets Swayampakula Ramakanth - H.C. Wainwright Operator Greetings, and welcome to the Ekso Bionics Quarter Three 2024 Financial Results Call.

Ekso Bionics Announces Third Quarter 2024 Financial Results
globenewswire.com28 October 2024 Sentiment: POSITIVE

SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and nine months ended September 30, 2024.

Ekso Bionics to Report Third Quarter 2024 Financial Results on October 28, 2024
globenewswire.com21 October 2024 Sentiment: POSITIVE

SAN RAFAEL, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the third quarter 2024 after the close of trading on Monday, October 28, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

Ekso Bionics (EKSO) Addressable Market to Grow on CMS Update
zacks.com26 August 2024 Sentiment: POSITIVE

Ekso Bionics EKSO has reached a significant milestone in terms of transforming mobility solutions, particularly for individuals with spinal cord injuries (SCI). The company recently secured initial reimbursement from the Centers for Medicare & Medicaid Services (CMS) for its Ekso Indego Personal exoskeleton.

Why Is Ekso Bionics (EKSO) Stock Down 15% Today?
investorplace.com30 July 2024 Sentiment: NEGATIVE

Ekso Bionics (NASDAQ: EKSO ) stock is taking a beating on Tuesday following the release of the exoskeleton company's Q2 earnings report. The bad news for Ekso Bionics starts with its diluted earnings per share of -13 cents.

Ekso Bionics Reports Record Quarterly Sales of $5.0 Million in Second Quarter 2024
globenewswire.com29 July 2024 Sentiment: POSITIVE

SAN RAFAEL, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company” or “Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today reported financial results for the three and six months ended June 30, 2024.

Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024
globenewswire.com22 July 2024 Sentiment: POSITIVE

SAN RAFAEL, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will release financial and business results for the second quarter 2024 after the close of trading on Monday, July 29, 2024. Management will host a conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET to discuss the financial results and recent business developments.

  • 1(current)

What type of business is Ekso Bionics Holdings?

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

What sector is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Healthcare sector

What industry is Ekso Bionics Holdings in?

Ekso Bionics Holdings is in the Medical Instruments & Supplies industry

What country is Ekso Bionics Holdings from?

Ekso Bionics Holdings is headquartered in United States

When did Ekso Bionics Holdings go public?

Ekso Bionics Holdings initial public offering (IPO) was on 17 January 2014

What is Ekso Bionics Holdings website?

https://www.eksobionics.com

Is Ekso Bionics Holdings in the S&P 500?

No, Ekso Bionics Holdings is not included in the S&P 500 index

Is Ekso Bionics Holdings in the NASDAQ 100?

No, Ekso Bionics Holdings is not included in the NASDAQ 100 index

Is Ekso Bionics Holdings in the Dow Jones?

No, Ekso Bionics Holdings is not included in the Dow Jones index

When was Ekso Bionics Holdings the previous earnings report?

No data

When does Ekso Bionics Holdings earnings report?

The next expected earnings date for Ekso Bionics Holdings is 04 March 2025